Pentazocine
From Wikipedia, the free encyclopedia
| Image:Pentazocine.png | |
| Pentazocine
| |
| Systematic (IUPAC) name | |
| (1S,9S,13S)-1,13-dimethyl-10-(3-methylbut-2-en-1-yl)- 10-azatricyclo[7.3.1.02,7]trideca-2,4,6-trien-4-ol | |
| Identifiers | |
| CAS number | 359-83-1 |
| ATC code | N02AD01 |
| PubChem | 441278 |
| DrugBank | APRD01173 |
| Chemical data | |
| Formula | C19H27NO |
| Mol. weight | 285.424 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ~20% orally |
| Metabolism | Hepatic |
| Half life | 2 to 3 hours |
| Excretion | Renal |
| Therapeutic considerations | |
| Pregnancy cat. |
C/D (U.S.) |
| Legal status |
Schedule IV (U.S.) |
| Routes | Oral |
Pentazocine is a synthetically-prepared narcotic drug used to treat mild to moderate pain. Pentazocine is sold under several brand names, such as Talwin.
In the 1980s, recreational drug users discovered that combining pentazocine with the antihistamine tripellenamine (most commonly dispensed under the brand name Pyribenzamine) produced a euphoric sensation much like that brought on by heroin, and users who were already addicted to the latter often used this combination when heroin was unavailable to them. Since tripellenamine tablets are typically blue in color, the pentazocine/tripellenamine combination acquired the slang name Ts and blues. After health-care professionals and drug-enforcement officials became aware of this scenario, the narcotic-antagonist naloxone was added to preparations containing pentazocine, and the reported incidence of its abuse has declined precipitously since.
In a study published in the March 24, 2003 issue of the Proceedings of the National Academy of Sciences, a team led by McGill University researcher Jeffrey Mogil found that women with red hair require less pentazocine for pain relief than do women with other hair colours or men of any hair colour.
Pentazocine is still classified in Schedule IV under the Controlled Substances Act in the United States, even with the addition of the naloxone. Internationally, pentazocine is a Schedule III drug under the Convention on Psychotropic Substances[1].
[edit] External links
